- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/765 - RéovirusRotavirus
Détention brevets de la classe A61K 35/765
Brevets de cette classe: 61
Historique des publications depuis 10 ans
4
|
5
|
7
|
10
|
11
|
3
|
5
|
3
|
3
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Oncolytics Biotech Inc. | 49 |
14 |
Virocure, Inc. | 21 |
12 |
Hangzhou Converd Co., Ltd. | 34 |
6 |
The Governors of the University of Alberta | 885 |
2 |
Osaka University | 3305 |
2 |
Universite Catholique de Louvain | 291 |
2 |
Aleta Biotherapeutics Inc. | 29 |
2 |
Sator Therapeutics LLC | 5 |
2 |
Centre National de La Recherche Scientifique | 10140 |
1 |
Aphp (assistance Publique-hopitaux de Paris) | 66 |
1 |
Aridis Pharmaceuticals Inc. | 30 |
1 |
Benevir Biopharm, Inc. | 9 |
1 |
British Columbia Cancer Agency Branch | 195 |
1 |
Children's Healthcare of Atlanta, Inc. | 241 |
1 |
Cornell University | 3215 |
1 |
Emory University | 1592 |
1 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2637 |
1 |
Ramot at Tel-Aviv University Ltd. | 1447 |
1 |
The United States of America, as represented by the Secretary, Department of Health and Human Serv | 39 |
1 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2844 |
1 |
Autres propriétaires | 7 |